18 January 2005 | Volume 142 Issue 2 | Pages 81-85
Background: Many expert panels recommend colorectal cancer screening for average-risk asymptomatic individuals older than 50 years of age. Recent studies have found that 24% to 64% of primary care providers use only the digital fecal occult blood test (FOBT) as their primary screening test. The effectiveness of a single digital FOBT is unknown.
Objective: To compare the sensitivity and specificity of digital FOBT and the recommended 6-sample at-home FOBT for advanced neoplasia in asymptomatic persons.
Design: Prospective cohort study.
Setting: 13 Veterans Affairs medical centers.
Patients: 3121 asymptomatic patients 50 to 75 years of age.
Intervention: 2665 patients had 6-sample at-home FOBT and digital FOBT, followed by complete colonoscopy.
Measurements: We measured the sensitivity of digital and 6-sample FOBT for advanced neoplasia and the specificity for no neoplasia. We calculated predictive values and likelihood ratios for advanced neoplasia, defined as tubular adenomas 10 mm or greater, adenomas with villous histology or high-grade dysplasia, or invasive cancer.
Results: Of all participants, 96.8% were men; their average age was 63.1 years. The 6-sample FOBT and the single digital FOBT had specificities of 93.9% and 97.5%, respectively, as defined by studying 1656 patients with no neoplasia. Sensitivities for detection of advanced neoplasia in 284 patients were 23.9% for the 6-sample FOBT and 4.9% for the digital FOBT. The likelihood ratio for advanced neoplasia was 1.68 (95% CI, 0.96 to 2.94) for positive results on digital FOBT and 0.98 (CI, 0.95 to 1.01) for negative results.
Limitations: Most patients were men.
Conclusions: Single digital FOBT is a poor screening method for colorectal neoplasia and cannot be recommended as the only test. When digital FOBT is performed as part of a primary care physical examination, negative results do not decrease the odds of advanced neoplasia. Persons with these results should be offered at-home 6-sample FOBT or another type of screening test.
Editors' Notes
Context
Contribution
Implications
The Editors
Author and Article Information
From Department of Veterans Affairs Medical Centers, Portland, Oregon, Long Beach, California, and Perry Point, Maryland.
*For a list of members of the Veterans Affairs Cooperative Study #380 Group, see the Appendix.
Grant Support: By the Cooperative Studies Program, Department of Veterans Affairs, Protocol #380.
Potential Financial Conflicts of Interest: None disclosed.
Requests for Single Reprints: Judith F. Collins, MD, Portland Veterans Affairs Medical Center, P3-GI, 3710 SW Veterans Hospital Road, PO Box 1034, Portland, OR 97239.
Current Author Addresses: Drs. Collins and Lieberman: Portland Veterans Affairs Medical Center, P3-GI, 3710 SW Veterans Hospital Road, PO Box 1034, Portland, OR 97239.
Dr. Durbin: West Anaheim Medical Offices, Suite 203, 3010 West Orange Street, Anaheim, CA 92804.
Dr. Weiss: Perry Point Veterans Affairs Medical Center, 151E, PO Box 1010, Perry Point, MD 21902.
Author Contributions: Conception and design: D.A. Lieberman, D.G. Weiss.
Analysis and interpretation of the data: J.F. Collins, D.A. Lieberman, T.E. Durbin, D.G. Weiss.
Drafting of the article: J.F. Collins, D.A. Lieberman, T.E. Durbin.
Critical revision of the article for important intellectual content: J.F. Collins, D.A. Lieberman, D.G. Weiss.
Final approval of the article: J.F. Collins, D.A. Lieberman, T.E. Durbin, D.G. Weiss.
Provision of study materials or patients: J.F. Collins, D.A. Lieberman, T.E. Durbin.
Statistical expertise: D.A. Lieberman, D.G. Weiss.
Obtaining of funding: D.A. Lieberman, D.G. Weiss.
Administrative, technical, or logistic support: D.G. Weiss.
Collection and assembly of data: J.F. Collins, D.A. Lieberman, T.E. Durbin, D.G. Weiss. ARTICLE
Accuracy of Screening for Fecal Occult Blood on a Single Stool Sample Obtained by Digital Rectal Examination: A Comparison with Recommended Sampling Practice
![]()
![]()
Related articles in Annals:
This article has been cited by other articles:
![]() |
D. A. Ahlquist, D. J. Sargent, C. L. Loprinzi, T. R. Levin, D. K. Rex, D. J. Ahnen, K. Knigge, M. P. Lance, L. J. Burgart, S. R. Hamilton, et al. Stool DNA and Occult Blood Testing for Screen Detection of Colorectal Neoplasia Ann Intern Med, October 7, 2008; 149(7): 441 - 450. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Levin, D. A. Lieberman, B. McFarland, R. A. Smith, D. Brooks, K. S. Andrews, C. Dash, F. M. Giardiello, S. Glick, T. R. Levin, et al. Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology CA Cancer J Clin, May 1, 2008; 58(3): 130 - 160. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Smith, V. Cokkinides, and O. W. Brawley Cancer Screening in the United States, 2008: A Review of Current American Cancer Society Guidelines and Cancer Screening Issues CA Cancer J Clin, May 1, 2008; 58(3): 161 - 179. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G Fraser Faecal occult blood tests - eliminate, enhance or update? Ann Clin Biochem, March 1, 2008; 45(2): 117 - 121. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Allison, L. C. Sakoda, T. R. Levin, J. P. Tucker, I. S. Tekawa, T. Cuff, M. P. Pauly, L. Shlager, A. M. Palitz, W. K. Zhao, et al. Screening for Colorectal Neoplasms With New Fecal Occult Blood Tests: Update on Performance Characteristics J Natl Cancer Inst, October 3, 2007; 99(19): 1462 - 1470. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Smith, V. Cokkinides, and H. J. Eyre Cancer Screening in the United States, 2007: A Review of Current Guidelines, Practices, and Prospects CA Cancer J Clin, March 1, 2007; 57(2): 90 - 104. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Levi, P. Rozen, R. Hazazi, A. Vilkin, A. Waked, E. Maoz, S. Birkenfeld, M. Leshno, and Y. Niv A Quantitative Immunochemical Fecal Occult Blood Test for Colorectal Neoplasia Ann Intern Med, February 20, 2007; 146(4): 244 - 255. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Basch, R. L. Wolf, C. H. Brouse, C. Shmukler, A. Neugut, L. T. DeCarlo, and S. Shea Telephone Outreach to Increase Colorectal Cancer Screening in an Urban Minority Population Am J Public Health, December 1, 2006; 96(12): 2246 - 2253. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. B. El-Serag, L. Petersen, H. Hampel, P. Richardson, and G. Cooper The use of screening colonoscopy for patients cared for by the department of veterans affairs. Arch Intern Med, November 13, 2006; 166(20): 2202 - 2208. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Roessler, W. Rollinger, L. Mantovani-Endl, M.-L. Hagmann, S. Palme, P. Berndt, A. M. Engel, M. Pfeffer, J. Karl, H. Bodenmuller, et al. Identification of PSME3 as a Novel Serum Tumor Marker for Colorectal Cancer by Combining Two-dimensional Polyacrylamide Gel Electrophoresis with a Strictly Mass Spectrometry-based Approach for Data Analysis Mol. Cell. Proteomics, November 1, 2006; 5(11): 2092 - 2101. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Greenberger and P. Sharma Update in Gastroenterology and Hepatology Ann Intern Med, August 15, 2006; 145(4): 294 - 298. [Full Text] [PDF] |
||||
![]() |
S. R. Martinez, S. E. Young, R. E. Hoedema, L. J. Foshag, and A. J. Bilchik Colorectal Cancer Screening and Surveillance: Current Standards and Future Trends Ann. Surg. Oncol., June 1, 2006; 13(6): 768 - 775. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. C. Taylor A 71-Year-Old Woman Contemplating a Screening Colonoscopy JAMA, March 8, 2006; 295(10): 1161 - 1167. [Full Text] [PDF] |
||||
![]() |
R. A. Smith, V. Cokkinides, and H. J. Eyre American Cancer Society Guidelines for the Early Detection of Cancer, 2006 CA Cancer J Clin, January 1, 2006; 56(1): 11 - 25. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Roessler, W. Rollinger, S. Palme, M.-L. Hagmann, P. Berndt, A. M. Engel, B. Schneidinger, M. Pfeffer, H. Andres, J. Karl, et al. Identification of Nicotinamide N-Methyltransferase as a Novel Serum Tumor Marker for Colorectal Cancer Clin. Cancer Res., September 15, 2005; 11(18): 6550 - 6557. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Brenner and G. Rennert Fecal DNA Biomarkers for the Detection of Colorectal Neoplasia: Attractive, but Is It Feasible? J Natl Cancer Inst, August 3, 2005; 97(15): 1107 - 1109. [Full Text] [PDF] |
||||
![]() |
R. C. Kane Accuracy of a Single Fecal Occult Blood Test in Screening for Colorectal Cancer Ann Intern Med, August 2, 2005; 143(3): 235 - 235. [Full Text] [PDF] |
||||
![]() |
M. L. Wolff Office-Based Testing for Fecal Occult Blood Ann Intern Med, August 2, 2005; 143(3): 235 - 235. [Full Text] [PDF] |
||||
![]() |
C. Jackson and R. Craig Office-Based Testing for Fecal Occult Blood Ann Intern Med, August 2, 2005; 143(3): 235 - 236. [Full Text] [PDF] |
||||
![]() |
H. H. Pham, D. Schrag, J. L. Hargraves, and P. B. Bach Delivery of Preventive Services to Older Adults by Primary Care Physicians JAMA, July 27, 2005; 294(4): 473 - 481. [Abstract] [Full Text] [PDF] |
||||
![]() |
DRE-Based FOBT: Common but Not Useful Journal Watch Women's Health, February 22, 2005; 2005(222): 8 - 8. [Full Text] |
||||
![]() |
Digital FOBT Often Used but Very Insensitive Journal Watch Gastroenterology, February 16, 2005; 2005(216): 7 - 7. [Full Text] |
||||
![]() |
DRE-Based FOBT: Common but Not Useful Journal Watch (General), February 1, 2005; 2005(201): 1 - 1. [Full Text] |
||||
![]() |
M. R. Nadel, J. A. Shapiro, C. N. Klabunde, L. C. Seeff, R. Uhler, R. A. Smith, and D. F. Ransohoff A National Survey of Primary Care Physicians' Methods for Screening for Fecal Occult Blood Ann Intern Med, January 18, 2005; 142(2): 86 - 94. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Sox Office-Based Testing for Fecal Occult Blood: Do Only in Case of Emergency Ann Intern Med, January 18, 2005; 142(2): 146 - 148. [Full Text] [PDF] |
||||
Read all Rapid Responses